ribavirin has been researched along with Anxiety Neuroses in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassiony, MM; El-Shabrawi, A; El-Shafeey, M; Fouad, E; Raya, Y; Yousef, A | 1 |
| A, Y; E, F; GM, Sel-D; H, AG; M, A; MM, B; MM, el-S; U, Y | 1 |
| Arribas, JR; Fraile, JM; González, JJ; Montes, ML | 1 |
| Mauss, S; Schaefer, M | 1 |
| Bezemer, G; de Knegt, RJ; Drenth, JP; Droogleever Fortuyn, HA; Hansen, BE; Hengeveld, MW; Janssen, HL; Van Gool, AR; Weegink, CJ | 1 |
| Ardevol, M; Castellví, P; Díez-Quevedo, C; Galeras, JA; García, F; Martín-Santos, R; Masnou, H; Miquel, M; Navinés, R; Planas, R; Solà, R; Soler, A | 1 |
| Blanc, D; Carrieri, MP; Dellamonica, P; Marcellin, F; Préau, M; Ravaux, I; Spire, B | 1 |
| Saunders, JC | 1 |
2 review(s) available for ribavirin and Anxiety Neuroses
| Article | Year |
|---|---|
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
Topics: Alcoholism; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Illicit Drugs; Interferon alpha-2; Interferon-alpha; Methadone; Narcotics; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Substance Abuse, Intravenous | 2008 |
Neuropsychiatric symptoms of hepatitis C.
Topics: Antiviral Agents; Anxiety Disorders; Brain; Chronic Disease; Cognition Disorders; Depressive Disorder, Major; Hepatitis C; Humans; Neuropsychological Tests; Ribavirin | 2008 |
2 trial(s) available for ribavirin and Anxiety Neuroses
| Article | Year |
|---|---|
Major depressive disorder and generalized anxiety disorder and response to treatment in hepatitis C patients in Egypt.
Topics: Adult; Antiviral Agents; Anxiety Disorders; Depressive Disorder, Major; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult | 2015 |
Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C.
Topics: Adult; Antiviral Agents; Anxiety Disorders; Citalopram; Double-Blind Method; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
4 other study(ies) available for ribavirin and Anxiety Neuroses
| Article | Year |
|---|---|
Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt.
Topics: Adolescent; Adult; Antiviral Agents; Anxiety Disorders; Case-Control Studies; Cognition Disorders; Depressive Disorder; Egypt; Female; Hepatitis C; Humans; Interferons; Male; Middle Aged; Prevalence; Prospective Studies; Ribavirin; Risk Factors; Surveys and Questionnaires; Young Adult | 2015 |
[Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].
Topics: Adult; Anti-HIV Agents; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Chorea; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Polypharmacy; Recombinant Proteins; Ribavirin; Sensation Disorders; Thyroiditis, Autoimmune; Thyroxine | 2009 |
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.
Topics: Adult; Antiviral Agents; Anxiety Disorders; Chi-Square Distribution; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Educational Status; Emigrants and Immigrants; Employment; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Treatment Outcome | 2008 |
Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.
Topics: Adult; Anger; Anti-Retroviral Agents; Antiviral Agents; Anxiety Disorders; Cross-Sectional Studies; Female; France; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Medical Records; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Surveys and Questionnaires; Treatment Outcome | 2008 |